Literature DB >> 10146277

The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

A R Clark1, A M Hollingworth.   

Abstract

Despite the fact that powder inhaler devices have been available for over 3 decades there is still very little fundamental information as to how powder inhaler design interacts with the airway dynamics of patients. This paper documents the results of human volunteer investigations designed to elucidate this interaction. These data indicates that if 'maximum' inhalation effort is employed the flow rate attained through an inhaler is controlled by the maximum pressure drop developed by the chest muscles. If a moderate or 'comfortable' effort is used, however, the relationship is more complex. An equation for defining the 'respirable fraction' of an inhalation aerosol cloud as a function of inhalation flow rate is also proposed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 10146277     DOI: 10.1089/jam.1993.6.99

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  59 in total

1.  Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers.

Authors:  V Chavan; R Dalby
Journal:  AAPS PharmSci       Date:  2000

2.  Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.

Authors:  Vasu V Sethuraman; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

3.  Aerosol dispersion of respirable particles in narrow size distributions produced by jet-milling and spray-drying techniques.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

4.  Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.

Authors:  Margaret D Louey; Michiel Van Oort; Anthony J Hickey
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 5.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

6.  Effects of device and formulation on in vitro performance of dry powder inhalers.

Authors:  Wallace P Adams; Sau L Lee; Robert Plourde; Robert A Lionberger; Craig M Bertha; William H Doub; Jean-Marc Bovet; Anthony J Hickey
Journal:  AAPS J       Date:  2012-04-05       Impact factor: 4.009

7.  Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?

Authors:  Patricia Tang; Philip Chi Lip Kwok; Zhenbo Tong; Runyu Yang; Judy Agnes Raper; Hak-Kim Chan
Journal:  Pharm Res       Date:  2012-02-11       Impact factor: 4.200

8.  Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers.

Authors:  Jagdeep Shur; Sau Lee; Wallace Adams; Robert Lionberger; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2012-06-22       Impact factor: 4.009

9.  Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery.

Authors:  Philip Chi Lip Kwok; Amolnat Tunsirikongkon; William Glover; Hak-Kim Chan
Journal:  Pharm Res       Date:  2010-12-07       Impact factor: 4.200

10.  Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.

Authors:  Francesca Buttini; James Hannon; Kristi Saavedra; Irene Rossi; Anna Giulia Balducci; Hugh Smyth; Andy Clark; Paolo Colombo
Journal:  Pharm Res       Date:  2016-09-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.